印度2026年的运动目标是124个地区进行大规模用药，力求在2027年前根除淋巴丝虫病。 India’s 2026 campaign targets 124 districts with mass drug rounds to eliminate lymphatic filariasis by 2027.

印度发起了2026年大规模药品管理局运动,争取到2027年消灭淋巴丝虫病,目标是12个州的124个县,每年向两岁以上的人提供DEC和Albendazole药物,但不包括孕妇和重病患者。 India has launched its 2026 Mass Drug Administration campaign to eliminate lymphatic filariasis by 2027, targeting 124 districts across 12 states with annual drug rounds of DEC and Albendazole for people over two, excluding pregnant women and those with severe illnesses. 该举措由联邦卫生部长Jagat Prakash Nadda牵头,重点是通过直接观察、社区参与和利用Ayushman Arogya Mandirs进行早期检测和根据Ayushman Bharat计划进行水文手术,改善合规情况。 The initiative, led by Union Health Minister Jagat Prakash Nadda, focuses on improving compliance through direct observation, community engagement, and leveraging Ayushman Arogya Mandirs for early detection and hydrocele surgeries under the Ayushman Bharat scheme. 虽然143个区在达到消除标准后已停止了MDA,但174个区因持续传播而继续停止,这场运动旨在克服偏远地区的挑战和加强监测,特别是在季风月份。 While 143 districts have stopped MDA after meeting elimination criteria, 174 continue due to ongoing transmission, with the campaign aiming to overcome challenges in remote areas and strengthen surveillance, especially during monsoon months.